Platelets and shear stress

Blood

Volumn 88, Issue 5, 1996, Pages 1525-1541

  Kroll, Michael H ^a,b   Hellums, J David ^a   McIntire, Larry V ^a   Schafer, Andrew I ^a   Moake, Joel L ^a  

^a RICE UNIVERSITY   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 6; EPTIFIBATIDE; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; HEPARIN; IMMUNOGLOBULIN F(AB) FRAGMENT; MATRIX PROTEIN; PROSTACYCLIN; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

BLOOD RHEOLOGY; BLOOD VESSEL WALL; BLOOD VISCOSITY; CORONARY ARTERY DILATATION; HEMOLYTIC UREMIC SYNDROME; HEMOSTASIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; THROMBOCYTE AGGREGATION; THROMBOSIS; VON WILLEBRAND DISEASE;

EID: 0029836459     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1525.bloodjournal8851525     Document Type: Review

References (187)

1. Howard MA, Firkin BG: Ristocetin-A new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 26:362, 1971
2. Weiss HJ, Roger J, Brand H: Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII. J Clin Invest 52:2697, 1973
3. Ruggeri ZM, Zimmerman TS: von Willebrand factor and von Willebrand disease. Blood 70:895, 1987
4. Sadler JE: von Willebrand factor. J Biol Chem 266:22777, 1992
5. O'Brien JR: Shear-induced platelet aggregation. Lancet 335:711, 1990
6. Roth GJ: Developing relationships: Arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood 77:5, 1991
7. Roth GJ, Calverley DC: Aspirin, platelets, and thrombosis: Theory and practice. Blood 83:885, 1994
8. Turitto VT: Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb 6:139, 1982
9. Bird RB, Stewart WE, Lightfoot EN: Transport Phenomena. New York, NY, Wiley, 1960, p 42
10. Tangelder GJ, Slaaf DW, Arts T, Reneman RS: Wall shear rate in arterioles in vivo: Least estimates from platelet velocity profiles. Am J Physiol 254:H1059, 1988
11. Strony J, Beaudoin A, Brands D, Adelman B: Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. Am J Physiol Heart Circ Physiol 265:H1787, 1993
12. Born GVR: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927, 1962
13. Brown CH, Leverett LB, Lewis CW, Alfrey CP, Hellums JD: Morphological, biochemical and functional changes in human platelets subjected to shear stress. J Lab Clin Med 86:462, 1975
14. Anderson GH, Hellums JD, Moake JL, Alfrey CP Jr: Platelet response to shear stress: Changes in serotonin uptake, serotonin release, and ADP induced aggregation. Thromb Res 13:1039, 1978
15. Weiss HJ, Baumgartner HR, Tschopp TB, Turitto VT, Cohen D: Correction by factor VIII of the impaired platelet adhesion to subendothelium in von Willebrand's disease. Blood 51:267, 1978
16. Weiss HJ, Turitto VT and Baumgartner HR: Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. Shear rate-dependent decrease of adhesion in von Willebrand disease and the Bernard Soulier syndrome. J Lab Clin Med 92:750, 1978
17. Anderson GH, Hellums JD, Moake JL, Alfrey CP Jr: Platelet lysis and aggregation in shear fields. Blood 4:499, 1978
18. Sakariassen KS, Bolhuis PA, Sixma JJ: Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bond to the subendothelium. Nature 279:635, 1979
19. Baumgartner HR, Tschopp TB, Meyer D: Shear rate dependent inhibition of platelet adhesion and aggregation on collagenous surfaces by antibodies to human factor VIII/von Willebrand Factor. Br J Haematol 44:127, 1980
20. MacCallum, RN, O'Bannon W, Hellums JD, Alfrey CP, Lynch EC: Viscometric instruments for studies on red blood cell damage, in Gabelnick HL, Litt M (eds): Rheology of Biological Systems. Springfield, Ill. Charles C Thomas, 1973, p 70
21. Belval T, Hellums JD, Solis RT: The kinetics of platelet aggregation induced by fluid-shearing stress. Microvas Res 28:279, 1984
22. Giorgio TD, Hellums JD: A cone and plate viscometer for the continuous measurement of blood platelet activation. Biorheology 25:605, 1988
23. Fukuyama M, Sakai K, Itagaki I, Kawano K, Murata M, Kawai Y, Walanabe K, Handa M, Ikeda Y: Continuous measurement of shear-induced platelet aggregation. Thromb Res 54:253, 1989
24. Joist JH, Zeffren DI, Bauman JE: A programmable, computer-controlled cone-plate viscometer for the application of pulsatile shear stress to platelet suspensions. Biorheology 25:449, 1988
25. Chow TW, Hellums JD, Moake JL, Kroll MH: Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1:113, 1992
26. Dewey CF Jr, Bussolari SR, Gimbrone MA Jr, Davies PF: The dynamic response of vascular endothelial cells to fluid shear stress. J Biomed Eng 103:177, 1981
27. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr: Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 90:4591, 1993
28. Malek AM, Gibbons GH, Dzau VJ, Izumo S: Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest 92:2013, 1993
29. Wurzinger LJ, Opitz R, Wolf M, Schmid-Schonhein H: "Shear induced platelet activation" - A critical reappraisal. Biorheology 22:399, 1985
30. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH and Hellums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78:1456, 1986
31. Sixma JJ, Sakariassen KS, Beeser-Visser NH, Ottenhof-Rovers M, Bolhuis PA: Adhesion of platelets to human artery subendothelium. Effect of factor VIII-von Willebrand factor of various multimeric composition. Blood 63:128, 1984
32. Turitto VT, Weiss HJ, Baumgartner HR: Decreased platelet adhesion on vessel segments in von Willebrand's disease: A defect in initial attachment. J Lab Clin Med 102:551, 1983
33. Turitto VT, Weiss HJ, Baumgartner HR: Platelet interaction with rabbit subendothelium in von Willebrand's disease: Altered thrombus formation distinct from defective platelet adhesion. J Clin Invest 74:1730, 1984
34. Turitto VT, Weiss HJ, Zimmerman TS, Sussman II: Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion. Blood 65:823, 1985
35. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki Y, Anbo h, Kawai Y, Watanabe K, Itagaki I, Sakai K, Ruggeri ZM: The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 87:1234, 1991
36. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD: Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, is resistant to aspirin. Blood 71:1366, 1988
37. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL: Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69:625, 1987
38. Strony J, Phillips M, Brands D, Moake J, Adelman B: Aurintricarhoxylic acid in a canine model of coronary artery thrombosis. Circulation 81:1106, 1990
39. Schullek J, Jordan J, Montgomery RR: Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest 73:421, 1984
40. McCrary JK, Nolasco LH, Hellums JD, Kroll MH, Turner NA, Moake JL: Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng 23:787, 1995
41. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM: Characterization of the unique mechanisms mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 270:23353, 1995
42. Goto S, Ikeda Y, Murata M, Handa M, Takahashi E, Yoshioka A, Fujimura Y, Fukuyama M, Handa S: Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation. Circulation 86:1859, 1992
43. Wagner CT, Kroll MH, Chow TW, Hellums JD, Schafer AI: Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that bypasses vWf-Gp Ib interactions. Biorheology 1996 (in press)
44. Modderman PW, Admiraal LG, Sonnenberg A, von dem Borne AEGK: Glycoprotein V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 267:364, 1992
45. López JA: The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrin 5:97, 1994
46. Hardwick RA, Hellums JD, Peterson DM, Moake JL, Olson JD: The effect of PGI2 and theophylline on the response of platelets subjected to shear stress. Blood 58:678, 1981
47. Durante W, Schafer AI, Hrbolich JK, Claure RA, Mendelsohn ME, Kroll MH: Endothelium-derived relaxing factor inhibits shear stress-induced platelet aggregation. Platelets 4:135, 1993
48. Alevriadou BR, Moake JL, Ruggeri ZM, Turner NA, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV: Real-time analysis of shear dependent thrombus formation and its blockade by inhibitors on von Willebrand factor binding to platelets. Blood 81:1263, 1993
49. Wurzinger LJ, Opitz R, Schmid-Schöbein H: Effect of anticoagulants on shear-induced platelet alterations. Thromb Res 49:133, 1987
50. van Zanten GH, de Graaf S, Slootweg PJ, Heijnen HFG, Connolly TM, de Groot PG, Sixma JA: Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 93:615, 1994
51. Kamat SG, Michelson AD, Benoit SE, Moake JL, Rajasekhar D, Hellums JD, Kroll MH, Schafer AI: Fibrinolysis inhibits shear stress-induced platelet aggregation. Circulation 92:1399, 1995
52. Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawakami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM: Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost 69:496, 1993
53. Konstantopoulos K, Hellums JD, Turner NT, Moake JL: Flow-cytometric analyses of shear stress-induced von Willebrand factor binding to platelets. Circulation 1996 (submitted)
54. Konstantopoulos K, Wu KK, Udden MM, Banez EI, Shattil SJ, Hellums JD: Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 32:73, 1995
55. Shattil S, Brass LF: Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 262:992, 1987
56. van Willigen G, Akkerman J-WN: Regular of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin. Blood 79:82, 1992
57. Shattil S, Cunningham M, Wiedmer T, Zhao J, Sims P, Brass L: Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. J Biol Chem 267:18424, 1992
58. Kovacsovics TJ, Bachelot C, Toker A, Vlahos CJ, Duckworth B, Cantley LC, Hartwig JH: Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation. J Biol Chem 270:11358, 1995
59. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan K, Hrbolich J, Schafer A: Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 268:3520, 1993
60. Razdan K, Hellums JD, Kroll MH: Shear stress-induced von willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem J 302:681, 1994
61. Kroll MH, Dong JF, Francis K, Hellums JD, Vlahos CJ, López JA: Shear stress activates a functionally important phosphatidylinositol 3-kinase in intact human platelets. Blood 86:612a, 1995 (abstr, suppl I)
62. López JA, Ludwig EH, McCarthy BJ: Polymorphism of human glycoprotein Ib results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycoprotein region. J Biol Chem 267:10055, 1992
63. Fox JEB, Berndt MC: Cyclic AMP-dependent phosphorylation of glycoprotein Ib inhibits collagen-induced polymerization of actin in platelets. J Biol Chem 264:9520, 1989
64. Lerea KM, Glomset JA: Agents that elevate the concentration of cAMP in platelets inhibit the formation of a NaDodSO4-resistant complex between thrombin and a 40-kDa protein. Proc Natl Acad Sci USA 84:5620, 1987
65. Huang PY, Hellums JD: Aggregation and disaggregation kinetics of human blood platelets: Parts I, II, and III. Biophys J 65:334, 1993
66. Hellums JD: 1993 Whitaker lecture: Biorheology in thrombosis research. Ann Biomed Eng 22:445, 1994
67. Wurzinger LJ, Opitz R, Blasberg P, Schmid-Schonbein H: Platelet and coagulation parameters following millsecond exposure to laminar shear stress. Thromb Haemost 54:381, 1985
68. Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V: Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: Deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med 110:706, 1987
69. Bell DN, Spain S, Goldsmith HL: Adenosine disphosphate-induced aggregation of human platelets in flow through tubes. Biophys J 56:817, 1989
70. Tschopp TB, Weiss HI, Baumgartner HR: Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med 83:296, 1974
71. Muggli R, Baumgartner HR, Tschopp TB, Keller H: Automated microdensitometry and protein assay as a measure for platelet adhesion and aggregation on collagen-coated slides under controlled flow conditions. J Lab Clin Med 95:195, 1980
72. Sakariassen KS, Aarts PAMM, De Groot PG, Houdijk WPM, Sixma JJ: A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med 102:522, 1983
73. Folie BJ, McIntire LV, Lasslo A: Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass. Blood 72:1393, 1988
74. O'Brien JR, Salmon GP: Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factory causes aggregation: Filter blockage and the long bleeding time in von Willebrand's disease. Blood 70:1354, 1987
75. Polanowska-Grabowska R, Gear ARL: High-speed platelet adhesion under conditions of rapid flow. Proc Natl Acad Sci USA 89:5754, 1992
76. Weiss HJ, Turitto VT, Baumgartner HR: Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood 67:322, 1986
77. Sakariassen K, Nievelstein P, Coller B, Sixma J: The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol 63:681, 1986
78. Stel HV, Sakariassen KS, De Groot PG, Van Mourik JA, Sixma JJ: von Willebrand factor in the vessel wall mediates platelet adherence. Blood 65:85, 1985
79. Grabowski EF: Platelet aggregation in flowing blood at a site of injury to an endothelial cell monolayer: Quantitation and real-time imaging with the TAB monclonal antibody. Blood 75:390, 1990
80. Baumgartner HR, Muggli R, Tschopp TB, Turitto VT: Platelet adhesion, release and aggregation in flowing blood: Effects of surface properties, and platelet function. Thromb Haemost 35:124, 1976
81. Tschopp TB, Baumgartner HR: Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats rabbits and guinea pigs correlate negatively with the vascular PG12-production. J Lab Clin Med 98:402, 1981
82. Weiss HJ, Turitto VT, Baumgartner HR: Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. J Clin Invest 78:1072, 1986
83. Kirchhofer D, Tschopp TB, Steiner BT, Baumgartner HR: Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood. Blood 86:3815, 1995
84. Turitto VT, Baumgartner HR: Initial deposition of platelets and fibrin on vascular surfaces in flowing blood, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis (ed 3). Philadelphia, PA, Lippincott, 1994, p 805
85. Morton LF, Barnes MJ: Collagen polymorphisms in the normal and diseased blood vessel wall. Atherosclerosis 42:41, 1982
86. Barnes MJ: Collagen polymorphisms in the normal and diseased blood vessel wall. Atherosclerosis 46:249, 1983
87. Barnes MJ: Collagens in atherosclerosis. Collagen Rel Res 5:65, 1985
88. Murata K, Motayama T, Kotake C: Collagen types in various layers of human aorta and their changes with the atherosclerosis process. Atherosclerosis 60:251, 1986
89. Shekhonin BV, Bomogatsky SP, Idelson GL, Koteliansky VE, Rukosuev WS: Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis 67:9, 1987
90. Gay S, Balleisen L, Rember K, Fietzek PP, Adelmann BC, Kuhn K: Immunohistochemical evidence for the presence of collagen type III in human arterial walls, arterial thrombi and in leukocytes, incubated with collagen in vitro. Klin Wschr 53:899, 1975
91. McCullagh KG: Increased type I collagen in human atherosclerotic plaque. Atherosclerosis 46:247, 1983
92. Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM: Isolation and characterization of a collagen binding domain in human von Willebrand factor. J Biol Chem 261:15310, 1986
93. De Groot PG, Ottenhof-Rovers M, Van Mourik JA, Sixma JJ: Evidence that the primary binding site of von Willebrand factor that mediates platelet adhesion to subendothelium is not collagen. J Clin Invest 82:65, 1988
94. Rand JH, Patel ND, Schwartz E, Zhou S-L, Potter BJ: 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 88:253, 1991
95. Sixma JJ, Schiphorst ME, Verweij CL, Pannekoeck H: Effect of deletion of the A1 domain on von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem 196:369, 1991
96. Houdijk WPM, Sakariassen KS, Nievelstein PFEM, Sixma JJ: Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar collagen types I and III. J Clin Invest 75:531, 1985
97. Sakariassen KS, Fressinaud E, Girma JP, Baumgartner HR, Meyer D: Mediation of platelet adhesion to fibrillar collagen in flowing blood by a proteolytic fragment of human von Willebrand factor. Blood 67:1515, 1986
98. Fressinaud E, Baruch D, Rothschild C, Baumgartner HR, Meyer D: Platelet von Willebrand factor: Evidence for its involvement in platelet adhesion to collagen. Blood 70:1214, 1987
99. D'Alessio P, Zwaginga JJ, De Boer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, De Groot PG, Sixma JJ: Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor. Thromb Haemos 64:227, 1990
100. Kroll MH, Schafer AI: The analysis of ligand-receptor interactions in platelet activation, in Joseph M (ed): The Immunopharmacology of Plalelets. London, UK, Academic, 1995
101. Coller BS, Beer JH, Scudder LE, Steinberg MH: Collagenplatelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb-IIIa mediated by adhesive proteins. Blood 74:182, 1989
102. Baruch D, Denis C, Marteaux C, Schoevaert D, Coulombel L, Meyer D: Role of von Willebrand factor associated with extracellular matrices in platelet adhesion. Blood 77:519, 1991
103. Olson JD, Zaleski A, Hermann D, Flood PA: Adhesion of platelets to purified solid-phase von Willebrand factor: Effects of wall shear rate, ADP, thrombin, and ristocetin. J Lab Clin Med 114:6, 1989
104. Badimon L, Badimon JJ, Rand J, Turrito VT, Fuster V: Platelet deposition on von Willebrand factor-deficient vessels. Extra-corporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. J Lab Clin Med 110:634, 1987
105. Bolhuis PA, Sakariassen KS, Sander HJ, Bouma BN, Sixma JJ: Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med 97:568, 1981
106. Smith EB, Keen GA, Grant A, Stirk C: Fate of fibrinogen in human arterial intima. Arteriosclerosis 10:263, 1990
107. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL: Identification an ddistribution of fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis 9:109, 1989
108. Sheppeck RA, Bentz M, Dickson C, Hribar S, White J, Janosky J, Berceli SA, Borovetz HS, Johnson PC: Examination of the roles of glycoprotein Ib and glycoprotein IIb-IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade. Blood 78:673, 1991
109. Nagai H, Handa M, Kawai Y, Watanabe K, Ikeda Y: Evidence that plasma fibrinogen and platelet glycoprotein IIb-IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Thromb Res 71:467, 1993
110. Hantgan RR, Hindriks G, Taylor RG, Sixma JJ, de Groot P: Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb-IIIa are all involved in platelet adhesion to fibrin in flowing whole blood. Blood 76:345, 1990
111. Hantgan RR, Endenberg SC, Cavero I, Marguerie G, Uzan A, Sixma JJ, de Groot PG: Inhibition of platelet adhesion to fibrin (ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma chain carboxy terminal peptides. Thromb Haemost 68:694, 1992
112. Endenburg SC, Hantgan RR, Lindeboom-Blokzijl L, Lankhof H, Jerome WG, Lewis JC, Sixma JJ, de Groot PG: On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood. Blood 86:4158, 1995
113. Beumer S, Ijsseldijk MJW, de Groot PG, Sixma JJ: Platelet adhesion to fibronectin in flow: Dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GPIIb/IIIa and VLA-5, and inhibition by heparin. Blood 84:3724, 1994
114. Beumer S, Heijnen HFG, Ijsseldijk MJW, Orlando E, de Groot PG, Sixma JJ: Platelet adhesion to fibronectin in flow: The importance of von Willebrand factor and glycoprotein Ib. Blood 86:3452, 1995
115. Nievelstein PFEM, D'Alessio PA, Sixma JJ: Fibronectin in platelet adhesion to human-collagen types I and III. Use of nonfibrillar and fibrillar collagen in flowing blood studies. Arteriosclerosis 8:201, 1988
116. 2+ ions, shear rate, and platelet membrane glycoproteins. Blood 79:928, 1992
117. Agbanyo FR, Sixma JJ, de Groot PG, Languino LR, Plow EF: Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins. J Clin Invest 92:288, 1992
118. Kuo L, Davies MJ, Chilian WM: Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am J Physiol 259:H1063, 1990
119. Lamontagne D, Phol U, Busse R: Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70:127, 1992
120. Nabel EG, Selwyn AP, Ganz P: Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 16:349, 1990
121. Koller A, Sun D, Galey G: Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 72:1276, 1993
122. Rubanyi GM, Romero JC, Vanhoutte PM: Flow induced release of endothelium derived relaxing factor. Am J Physiol 250:H1145, 1986
123. Pohl U, Herlan K, Huang A, Bassenge E: EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol 261.-H2016, 1991
124. Kuo L, Chilian WM, Davis MJ: Interaction of pressure- and flow-induced responses in procine coronary resistant vessels. Am J Physiol 261:H1706, 1991
125. Randall MD, Griffith TM: EDRF plays central role in collateral flow after arterial occlusion in rabbit ear. Am J Physiol 263:H752, 1992
126. Ziegler T, Nerem RM: Tissue engineering a blood vessel: Regulation of vascular biology by mechanical stresses. J Cell Biochem 56:204, 1994
127. Nollert MU, Diamond SL, McIntire LV: Hydrodynamic shear stress and mass transport modulation of endothelial cell metabolism. Biotech Bioeng 38:588, 1991
128. Frangos JA, Eskin SG, McIntire LV, Ives CL: Flow effects on prostacyclin production by cultured human endothelial cells. Science 227:1477, 1985
129. Grabowski EF, Jaffe EA, Weksler BB: Prostacyclin production by cultured endothelial cell monolayers exposed to step increases in shear stress. J Lab Clin Med 105:36, 1985
130. Pohl U, Bausse R, Kuon E, Bassenger E, Pulsatile perfusion stimulates the release of endothelial autacoids. J Appl Cardiol 1:215, 1986
131. Carosi JA, Eskin SG, Mclntire LV: Cyclical strain effects on production of vasoactive materials in cultured endothelial cells. J Cell Physiol 151:29, 1992
132. Nathan C, Xie Q: Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725, 1994
133. Janssens SP, Shimouchi A, Quetermous T, Bloch DB, Block KD: Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519, 1992
134. Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T: Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307:297, 1992
135. Lamas S, Marsden PA, Li GK, Tempst P, Michel T: Endothelial nitric oxide synthase: Molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89:6348, 1992
136. Bredt DS, Synder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682, 1990
137. Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250:H1145, 1986
138. Rubanyi GM, Freay AD, Kauser K, Johns A, Harder DR: Mechanoreception by the endothelium: Mediators and mechanisms of pressure- and flow-induced vascular responses. Blood Vessels 27:246, 1990
139. Cook JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ: Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88:1663, 1991
140. Buga GM, Gold ME, Fukuto JM, Ignarro LG: Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17:187, 1991
141. Kuchan MJ, Frangos JA: Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 266:C628, 1994
142. Awolesi MA, Widman MD, Sessa WC, Sumpio BE: Cyclic strain increases endothelial nitric oxide synthase activity. Surgery 116:439, 1994
143. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ: Molecular cloning and characterization of the constitutive bovine endothelial cell nitric oxide synthase. J Clin Invest 90:2092, 1992
144. Awolesi MA, Sessa WC, Sumpio BE: Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 96:1449, 1995
145. MacArthur H, Hecker M, Busse R, Vane JR: Selective inhibition of agonist-induced but not shear stress-dependent release of endothelial autocoids by thapsigargin. Br J Pharmacol 108:100, 1993
146. Hutcheson IR, Griffith TM: Heterogeneous populations of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta. Am J Physiol 266:H590, 1994
147. Norris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76:536, 1995
148. Schafer AI, Adelman B: Plasmin inhibition of platelet function and of arachidonic acid metabolism. J Clin Invest 75:456, 1985
149. Coller BS: Platelets and thrombolytic therapy. N Engl J Med 322:33, 1990
150. Diamond SL, Eskin SG, McIntire LV: Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 243:1483, 1989
151. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, Mclntire LV, Eskin SG: Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 143:364, 1990
152. Carosi JA, McIntire LV: Effects of cyclical strain on the production of vasoactive materials by cultured human and bovine endothelial cells. Eur Respir Rev 3:598, 1993
153. + current in vascular endothelial cells. Nature 331:168, 1988
154. Davies PF: Endothelium as a signal transduction interface for flow forces: Cell surface dynamics. Thromb Heamost 70:124, 1993
155. 2+ coupling in vascular endothelial cells. Am J Physiol 261:H149, 1991
156. Patrick CW Jr, McIntire LV: Fluid shear stress effects on endothelial cell cytosolic pH. Tissue Eng 1:53, 1995
157. Davies PF, Tripathi SC: Mechanical stress mechanisms and the cell: An endothelial paradigm. Circ Res 72:239, 1993
158. Lansman JB, Hallam TJ, Rink TJ: Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature 325:811, 1987
159. + efflux from calf pulmonary artery endothelial cells. Ann Biomed Eng 21:1, 1993
160. Schwarz G, Droogmans G, Nilius B: Shear stress induced membrane currents and calcium transients in human vascular endothelial cells. Pflugers Arch 421:394, 1992
161. Shen J, Luscinskas W, Connolly A, Dewey CF Jr, Gimbrone MA Jr: Fluid shear stress modulates cytosolic free calcium in vascular endothelials cells. Am J Physiol 262:C384, 1992
162. 2+ signalling of vascular endothelial cells: Effect of shear stress and ATP. Am J Physiol 260:H1698, 1991
163. 2+ mobilization to mechanical stretch in endothelial cells. Am J Physiol 264:C1037, 1993
164. Kanai AJ, Strauss HC, Truskey GA, Crewes AL, Grunfeld S, Malinski T: Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res 77:284, 1995
165. Charles IG, Palmer R, Hickery RMJ, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondocyte. Proc Natl Acad Sci USA 90:11419, 1993
166. Prasad ARS, Logan SA, Nerem RB, Schwartz CJ, Sprague EA: Flow-related responses of intracellular inositol phosphate levels in cultured arotic endothelial cells. Circ Res 72:827, 1993
167. Nollert MU, Eskin SG, Mclntire LV: Shear stress increases inositol trisphosphate levels in human endothelial cells. Biochem Biophys Res Commun. 170:281, 1990
168. 2+ and protein kinase C in shear stress-induced actin depolymerization and endothelin 1 gene expression. Circ Res 75:630, 1994
169. Tseng H, Peterson TE, Berk BC: Fluid shear stress stimulates mitogen-activated protein kinase in endsthelial cells. Circ Res 77:869, 1995
170. Nollert MU, Panaro NJ, Mclntire LV: Regulation of genetic expression in shear stress-stimulated endothelial cells. Ann NY Acad Sci 664:94, 1992
171. Lan Q, Mercurius KO, Davies PF: Stimulation of transcription factors NFκB and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Commun 201950, 1994
172. Khachigian LM, Resnick N, Gimbrone Jr MA, Collins T: Nuclear factor-kB interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invent 96:1169, 1995
173. Shyy Jy-J, Lin M-C, Han J, Lu Y, Petrime M, Chien S: The cis-aching phorbol ester "12-0-tetradecanoylphorbol 13-acetate" - responsive element is involved in shear stress induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci USA 92:8069, 1995
174. Resnick N, Gimbrone MA Jr: Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9:874, 1995
175. 1 Blood 69:1504, 1987
176. MacDonald PS, Read MA, Dusting GJ: Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res 49:437, 1988
177. Radomski MW, Palmer RMJ, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92:639, 1987
178. Houston DS, Robinson P, Gerrard MJ: Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: Reversal by red blood cells. Blood 76:953, 1990
179. de Graaf JC, Banga JD, Moncada S, Palmer RMJ, de Groot PG, Sixma JJ: Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation 85:2284, 1992
180. Fauvel-Lafeve F, Legrand YJ: Binding of plasma von Willebrand factor by arterial microfibrils. Thromb Haemost 64:145, 1990
181. Ross JM, Mclntire LV, Moake JL, Rand JH: Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions. Blood 85:1826, 1995
182. 1-integrin). Blood 83:1244, 1994
183. Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, McIntire LV: Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 91:1354, 1995
184. Konstantopoulos K, Kamat SG, Schafer AI, Banez EI, Jordan R, Kleiman NS, Hellums JD: Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 fab, in patients undergoing coronary angioplasty. Circulation 91:1427, 1995
185. Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, Santiago-Borrero P, Horowitz M, Pehta J: Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood 84:490, 1994
186. Moake JL: Haemolytic-uraemic syndrome: basic science. Lancet 343:393, 1994
187. Alevriadou BR, McIntire LV: Rheology, in Loscalzo J, Schafer AI (eds): Thrombosis and Hemorrhage. Cambridge, MA, Blackwell Science, 1995, p 369